Xtant Medical Holdings Statistics
Total Valuation
XTNT has a market cap or net worth of $77.84 million. The enterprise value is $107.20 million.
Important Dates
The next estimated earnings date is Monday, March 31, 2025, before market open.
| Earnings Date | Mar 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
XTNT has 139.01 million shares outstanding. The number of shares has increased by 9.53% in one year.
| Current Share Class | 139.01M |
| Shares Outstanding | 139.01M |
| Shares Change (YoY) | +9.53% |
| Shares Change (QoQ) | +3.71% |
| Owned by Insiders (%) | 7.28% |
| Owned by Institutions (%) | 4.41% |
| Float | 36.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.65 |
| Forward PS | 0.59 |
| PB Ratio | 1.70 |
| P/TBV Ratio | 2.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.94 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.79.
| Current Ratio | 2.12 |
| Quick Ratio | 0.81 |
| Debt / Equity | 0.79 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.64 |
Financial Efficiency
Return on equity (ROE) is -35.03% and return on invested capital (ROIC) is -10.98%.
| Return on Equity (ROE) | -35.03% |
| Return on Assets (ROA) | -9.17% |
| Return on Invested Capital (ROIC) | -10.98% |
| Return on Capital Employed (ROCE) | -21.47% |
| Revenue Per Employee | $529,591 |
| Profits Per Employee | -$81,800 |
| Employee Count | 215 |
| Asset Turnover | 1.19 |
| Inventory Turnover | 1.17 |
Taxes
In the past 12 months, XTNT has paid $743,000 in taxes.
| Income Tax | 743,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.15% in the last 52 weeks. The beta is 0.34, so XTNT's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | -46.15% |
| 50-Day Moving Average | 0.50 |
| 200-Day Moving Average | 0.60 |
| Relative Strength Index (RSI) | 49.68 |
| Average Volume (20 Days) | 50,331 |
Short Selling Information
The latest short interest is 105,734, so 0.08% of the outstanding shares have been sold short.
| Short Interest | 105,734 |
| Short Previous Month | 114,784 |
| Short % of Shares Out | 0.08% |
| Short % of Float | 0.29% |
| Short Ratio (days to cover) | 1.74 |
Income Statement
In the last 12 months, XTNT had revenue of $113.86 million and -$17.59 million in losses. Loss per share was -$0.13.
| Revenue | 113.86M |
| Gross Profit | 69.33M |
| Operating Income | -14.00M |
| Pretax Income | -4.95M |
| Net Income | -17.59M |
| EBITDA | -9.91M |
| EBIT | -14.00M |
| Loss Per Share | -$0.13 |
Full Income StatementBalance Sheet
The company has $6.60 million in cash and $35.95 million in debt, giving a net cash position of -$29.35 million or -$0.21 per share.
| Cash & Cash Equivalents | 6.60M |
| Total Debt | 35.95M |
| Net Cash | -29.35M |
| Net Cash Per Share | -$0.21 |
| Equity (Book Value) | 45.73M |
| Book Value Per Share | 0.33 |
| Working Capital | 37.74M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$13.48 million and capital expenditures -$3.80 million, giving a free cash flow of -$17.28 million.
| Operating Cash Flow | -13.48M |
| Capital Expenditures | -3.80M |
| Free Cash Flow | -17.28M |
| FCF Per Share | -$0.12 |
Full Cash Flow StatementMargins
Gross margin is 60.89%, with operating and profit margins of -12.29% and -15.45%.
| Gross Margin | 60.89% |
| Operating Margin | -12.29% |
| Pretax Margin | -14.79% |
| Profit Margin | -15.45% |
| EBITDA Margin | -8.70% |
| EBIT Margin | -12.29% |
| FCF Margin | n/a |
Dividends & Yields
XTNT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.53% |
| Shareholder Yield | -9.53% |
| Earnings Yield | -22.59% |
| FCF Yield | -22.20% |
Analyst Forecast
The average price target for XTNT is $3.00, which is 435.71% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.00 |
| Price Target Difference | 435.71% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on February 14, 2018. It was a reverse split with a ratio of 0.08333:1.
| Last Split Date | Feb 14, 2018 |
| Split Type | Reverse |
| Split Ratio | 0.08333:1 |
Scores
XTNT has an Altman Z-Score of -1.11 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.11 |
| Piotroski F-Score | 3 |